Auxly Cannabis Group (DB:3KF) - Aandelenkoers, Nieuws & Analyse

3KF Overzicht aandelen

Auxly Cannabis Group Inc. is een bedrijf voor verpakte consumptiegoederen op de markt voor cannabisproducten in Canada. Meer informatie

3KF fundamentele analyse
Sneeuwvlok Score
Waardering	4/6
Toekomstige groei	0/6
Prestaties in het verleden	0/6
Financiële gezondheid	5/6
Dividenden	0/6

Beloningen

Verhandeld tegen 98.7% onder onze schatting van de reële waarde

Risicoanalyse

Zeer volatiele aandelenkoers in de afgelopen 3 maanden

Heeft geen betekenisvolle marktkapitalisatie ( €45M )

Aandeelhouders zijn het afgelopen jaar verwaterd

Auxly Cannabis Group Inc. Concurrenten

SynBiotic

DUSE:SBX

€27.9m

Cantourage Group

XTRA:HIGH

€57.6m

Biofrontera

XTRA:B8FK

€16.3m

Redx Pharma

DB:0RX

€65.0m

Prijsgeschiedenis en prestaties

Overzicht van alle hoogtepunten, veranderingen en prijsdalingen voor Auxly Cannabis Group
Historische aandelenkoersen
Huidige aandelenkoers	CA$0.021
52 Week Hoogtepunt	CA$0.049
52 Week Laag	CA$0.0062
Bèta	1.22
11 maand verandering	15.05%
3 maanden verandering	-13.71%
1 Jaar Verandering	205.71%
33 jaar verandering	-85.75%
5 jaar verandering	-94.94%
Verandering sinds IPO	-97.19%

Recent nieuws en updates

Recent updates

Rendement voor aandeelhouders

	3KF	DE Pharmaceuticals	DE Markt
7D	-39.2%	1.6%	1.1%
1Y	205.7%	-19.0%	7.2%

Rendement versus industrie: 3KF overtrof de German Pharmaceuticals industrie, die het afgelopen jaar een rendement -19 % opleverde.

Rendement versus markt: 3KF overtrof de German markt, die het afgelopen jaar een rendement opleverde van 7.2 %.

Prijsvolatiliteit

Is 3KF's price volatile compared to industry and market?
3KF volatility
3KF Average Weekly Movement	74.1%
Pharmaceuticals Industry Average Movement	7.0%
Market Average Movement	4.8%
10% most volatile stocks in DE Market	10.9%
10% least volatile stocks in DE Market	2.4%

Stabiele aandelenkoers: De aandelenkoers van 3KF is de afgelopen 3 maanden volatiel geweest.

Volatiliteit in de loop van de tijd: De wekelijkse volatiliteit van 3KF is het afgelopen jaar gestegen van 55% naar 74%.

Over het bedrijf

Opgericht	Werknemers	CEO	Website
1987	369	Hugo Alves	www.auxly.com

Auxly Cannabis Group Inc. is een bedrijf voor verpakte consumptiegoederen op de markt voor cannabisproducten in Canada. Het bedrijf richt zich op de ontwikkeling, productie en distributie van cannabisproducten voor wellness- en recreatieve consumenten. Het bedrijf biedt cannabisproducten aan in verschillende vormen, waaronder vape catridges, infused pre-rolls, pre-rolled, vape pens, gemalen en gedroogde bloem, concentraten, chocolade, soft chews, oliedruppels, capsules en topicals onder de merknamen KOLAB PROJECT, Dosecann, BACK FORTY, Foray en Parcel.

Auxly Cannabis Group Inc. Samenvatting

Hoe verhouden de winst en inkomsten van Auxly Cannabis Group zich tot de beurswaarde?
3KF fundamentele statistieken
Marktkapitalisatie	€30.37m
Inkomsten(TTM)	-€50.48m
Inkomsten(TTM)	€77.35m

0.4x

P/S-verhouding

-0.6x

Koers/Winstverhouding

Is 3KF overgewaardeerd?

Zie Reële waarde en waarderingsanalyse

Inkomsten en omzet

Belangrijkste winstgevendheidsstatistieken uit het laatste winstverslag (TTM)
3KF resultatenrekening (TTM)
Inkomsten	CA$114.61m
Kosten van inkomsten	CA$69.34m
Brutowinst	CA$45.27m
Overige uitgaven	CA$120.07m
Inkomsten	-CA$74.79m

Laatst gerapporteerde inkomsten

Sep 30, 2024

Volgende inkomensdatum

n.v.t.

Winst per aandeel (EPS)	-0.058
Brutomarge	39.50%
Nettowinstmarge	-65.26%
Schuld/Eigen Vermogen Verhouding	51.4%

Hoe presteerde 3KF op de lange termijn?

Bekijk historische prestaties en vergelijking

3KF Overzicht aandelen

Beloningen

Risicoanalyse

Auxly Cannabis Group Inc. Concurrenten

DUSE:SBX

€27.9m

XTRA:HIGH

€57.6m

XTRA:B8FK

€16.3m

DB:0RX

€65.0m

Prijsgeschiedenis en prestaties

Recent nieuws en updates

Third quarter 2024 earnings released: EPS: CA$0.003 (vs CA$0.033 in 3Q 2023)

Auxly Cannabis Group Inc. to Report Q3, 2024 Results on Nov 08, 2024

Second quarter 2024 earnings released: EPS: CA$0.002 (vs CA$0.013 loss in 2Q 2023)

Auxly Cannabis Group Inc. to Report Q2, 2024 Results on Aug 15, 2024

First quarter 2024 earnings released: CA$0.026 loss per share (vs CA$0.011 loss in 1Q 2023)

Auxly Cannabis Group Inc. to Report Q1, 2024 Results on May 13, 2024

Recent updates

Third quarter 2024 earnings released: EPS: CA$0.003 (vs CA$0.033 in 3Q 2023)

Auxly Cannabis Group Inc. to Report Q3, 2024 Results on Nov 08, 2024

Second quarter 2024 earnings released: EPS: CA$0.002 (vs CA$0.013 loss in 2Q 2023)

Auxly Cannabis Group Inc. to Report Q2, 2024 Results on Aug 15, 2024

First quarter 2024 earnings released: CA$0.026 loss per share (vs CA$0.011 loss in 1Q 2023)

Auxly Cannabis Group Inc. to Report Q1, 2024 Results on May 13, 2024

Auxly Cannabis Group Inc., Annual General Meeting, Jun 28, 2024

New minor risk - Shareholder dilution

Full year 2023 earnings released: CA$0.045 loss per share (vs CA$0.15 loss in FY 2022)

Auxly Cannabis Group Inc. to Report Q4, 2023 Results on Mar 25, 2024

Third quarter 2023 earnings released: EPS: CA$0.033 (vs CA$0.067 loss in 3Q 2022)

Auxly Cannabis Group Inc. to Report Q3, 2023 Results on Nov 13, 2023

Insufficient new directors

New major risk - Market cap size

New major risk - Financial position

Second quarter 2023 earnings released: CA$0.013 loss per share (vs CA$0.016 loss in 2Q 2022)

Auxly Cannabis Group Inc. to Report Q2, 2023 Results on Aug 14, 2023

Auxly Cannabis Group Inc. Announces Executive Changes

First quarter 2023 earnings released: CA$0.011 loss per share (vs CA$0.047 loss in 1Q 2022)

Auxly Cannabis Group Inc. to Report Q1, 2023 Results on May 15, 2023

Full year 2022 earnings released: CA$0.15 loss per share (vs CA$0.059 loss in FY 2021)

Auxly Cannabis Group Inc. announced that it has received CAD 3.36 million in funding

Auxly Cannabis Group Inc. announced that it expects to receive CAD 3.36 million in funding

Morganti & Co. Issues Auxly Cannabis Group, Inc. Shareholder Class Action Notice of Certification

Third quarter 2022 earnings released: CA$0.067 loss per share (vs CA$0.016 loss in 3Q 2021)

Auxly Cannabis Group Inc. to Report Q3, 2022 Results on Nov 14, 2022

Second quarter 2022 earnings released: CA$0.016 loss per share (vs CA$0.005 loss in 2Q 2021)

An unknown buyer acquired Outdoor cultivation facility located in Hortonville, Nova Scotia from Auxly Cannabis Group Inc. (TSX:XLY) for CAD 4.1 million.

Auxly Cannabis Group Inc. to Report Q2, 2022 Results on Aug 15, 2022

Auxly Cannabis Group Inc. Introduces Edi's by Foray with the Launch of Large-Pack, Snackable Edibles

An unknown buyer acquired Auxly Annapolis Inc from Auxly Cannabis Group Inc. (TSX:XLY) for CAD 6 million.

Auxly Cannabis Group Inc. Reports Impairment Changes for the First Quarter Ended March 31, 2022

First quarter 2022 earnings released: CA$0.047 loss per share (vs CA$0.015 loss in 1Q 2021)

Auxly Cannabis Group Inc. to Report Q1, 2022 Results on May 16, 2022

Auxly Cannabis Group Inc., Annual General Meeting, Jun 30, 2022

Auxly Cannabis Group Inc. Announces Close of Robinsons Cultivation Facilities

KSM Securities Litigation Group Announces Ontario Court Grants Leave to Shareholders to Advance Statutory Claim Against Auxly Cannabis Securities Class Action

Forecast to breakeven in 2024

Auxly Cannabis Group Inc. (TSX:XLY) acquired Sunens Farms Inc. from Peter Quiring for CAD 5 million.

Third quarter 2021 earnings released: CA$0.016 loss per share (vs CA$0.028 loss in 3Q 2020)

Second quarter 2021 earnings released: CA$0.005 loss per share (vs CA$0.046 loss in 2Q 2020)

Auxly Cannabis Group Inc. on Hot Streak Heading into Summer Packed with New Products

Auxly Cannabis Group Inc. has completed a Composite Units Offering in the amount of CAD 15.0003 million.

CEO & Director recently bought €115k worth of stock

Myconic Capital Corp. (DB:MY0) completed the acquisition of KGK Science Inc. from Auxly Cannabis Group Inc. (TSX:XLY).

Myconic Capital Corp. (DB:MY0) entered into a definitive share purchase agreement to acquire KGK Science Inc. from Auxly Cannabis Group Inc. (TSX:XLY) for CAD 16.5 million.

First quarter 2021 earnings released: CA$0.015 loss per share (vs CA$0.02 loss in 1Q 2020)

Auxly Cannabis Group Inc. announced that it has received CAD 8 million in funding

Auxly Cannabis Group Inc. announced that it expects to receive CAD 8 million in funding

Full year 2020 earnings released: CA$0.14 loss per share (vs CA$0.17 loss in FY 2019)

Auxly Cannabis Group Inc. Announces Strategic Expansion into Cannabis 1.0

Namaste Technologies Announces Expansion of Product Range to Canadian Medical Customers at CannMart.com with the Addition of Leading Licensed Producers Including Auxly and TGOD

New 90-day high: €0.28

Auxly Cannabis Group Inc. has completed a Composite Units Offering in the amount of CAD 17.501 million.

New 90-day high: €0.25

Auxly Cannabis Group Inc. has completed a Composite Units Offering in the amount of CAD 12 million.

Third quarter 2020 earnings released: CA$0.028 loss per share

Revenue beats expectations

Dosecann Introduces Cannabis Capsules With Omega-Rich Ahiflower® Oil, A Truly Differentiated Product for the Wellness Consumer